APA

Anderson S. M., Buckingham B. A., Breton M. D., Robic J. L., Barnett C. L., Wakeman C. A., Oliveri M. C., Brown S. A., Ly T. T., Clinton P. K., Hsu L. J., Kingman R. S., Norlander L. M., Loebner S. E., Reuschel-DiVirglio S. & Kovatchev B. P. (20200410). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. : Diabetes technology & therapeutics.

Chicago

Anderson Stacey M, Buckingham Bruce A, Breton Marc D, Robic Jessica L, Barnett Charlotte L, Wakeman Christian A, Oliveri Mary C, Brown Sue A, Ly Trang T, Clinton Paula K, Hsu Liana J, Kingman Ryan S, Norlander Lisa M, Loebner Sarah E, Reuschel-DiVirglio Suzette and Kovatchev Boris P. 20200410. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. : Diabetes technology & therapeutics.

Harvard

Anderson S. M., Buckingham B. A., Breton M. D., Robic J. L., Barnett C. L., Wakeman C. A., Oliveri M. C., Brown S. A., Ly T. T., Clinton P. K., Hsu L. J., Kingman R. S., Norlander L. M., Loebner S. E., Reuschel-DiVirglio S. and Kovatchev B. P. (20200410). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. : Diabetes technology & therapeutics.

MLA

Anderson Stacey M, Buckingham Bruce A, Breton Marc D, Robic Jessica L, Barnett Charlotte L, Wakeman Christian A, Oliveri Mary C, Brown Sue A, Ly Trang T, Clinton Paula K, Hsu Liana J, Kingman Ryan S, Norlander Lisa M, Loebner Sarah E, Reuschel-DiVirglio Suzette and Kovatchev Boris P. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. : Diabetes technology & therapeutics. 20200410.